-
EU scrambles to seal climate targets before COP30
-
Getty Images largely loses lawsuit against UK AI firm
-
Cement maker Lafarge on trial in France over jihadist funding
-
Sculpture of Trump strapped to a cross displayed in Switzerland
-
Pakistan's Rauf and Indian skipper Yadav punished over Asia Cup behaviour
-
Libbok welcomes 'healthy' Springboks fly-half competition
-
Reeling from earthquakes, Afghans fear coming winter
-
Ronaldo reveals emotional retirement will come 'soon'
-
Munich's surfers stunned after famed river wave vanishes
-
Iran commemorates storming of US embassy with missile replicas, fake coffins
-
Gauff sweeps Paolini aside to revitalise WTA Finals defence
-
Shein vows to cooperate with France in probe over childlike sex dolls
-
Young leftist Mamdani on track to win NY vote, shaking up US politics
-
US government shutdown ties record for longest in history
-
King Tut's collection displayed for first time at Egypt's grand museum
-
Typhoon flooding kills over 40, strands thousands in central Philippines
-
Trent mural defaced ahead of Liverpool return
-
Sabalenka to face Kyrgios in 'Battle of Sexes' on December 28
-
Experts call for global panel to tackle 'inequality crisis'
-
Backed by Brussels, Zelensky urges Orban to drop veto on EU bid
-
After ECHR ruling, Turkey opposition urges pro-Kurd leader's release
-
Stocks drop as tech rally fades
-
UK far-right activist Robinson cleared of terror offence over phone access
-
World on track to dangerous warming as emissions hit record high: UN
-
Nvidia, Deutsche Telekom unveil 1-bn-euro AI industrial hub
-
Which record? Haaland warns he can get even better
-
Football star David Beckham hails knighthood as 'proudest moment'
-
Laurent Mauvignier wins France's top literary award for family saga
-
Indian Sikh pilgrims enter Pakistan, first major crossing since May conflict
-
Former US vice president Dick Cheney dies at 84
-
Fiorentina sack Pioli after winless start in Serie A
-
Stocks drop as traders assess tech rally
-
Oscar-winning Palestinian films daily 'Israeli impunity' in West Bank
-
Spain's Telefonica shares drop on dividend cut, net loss
-
Fierce mountain storms kill nine in Nepal
-
Divisive Czech cardinal Dominik Duka dies at 82
-
Shein vows to cooperate with France in sex doll probe
-
EU in last-ditch push to seal climate targets before COP30
-
Finnish ex-PM Marin says her female cabinet faced torrent of sexism
-
Sudan army-backed council to meet on US truce proposal: govt source
-
BP profit surges despite lower oil prices
-
Shein vows to cooperate with France in childlike sex doll probe
-
National hero proposal for Indonesia's Suharto sparks backlash
-
Indian great Ashwin out of Australia's BBL after knee surgery
-
Indian Sikh pilgrims enter Pakistan, first major crossing since May conflict: AFP
-
Asian markets slip as traders eye tech rally, US rate outlook
-
Nintendo hikes Switch 2 annual unit sales target
-
Typhoon flooding kills 5, strands thousands in central Philippines
-
Jobe Bellingham finding his feet as Dortmund head to City
-
US civil trial to hear opening arguments on Boeing MAX crash
Aprecia and Apprentice.io Partner to Scale Pharmaceutical 3D Printing Manufacturing
Aprecia will use Apprentice.io's AI-powered platform to scale its innovative technology for drug delivery solutions
Aprecia will use Apprentice.io's AI-powered platform to scale its innovative technology for drug delivery solutions
JERSEY CITY, NJ / ACCESS Newswire / September 16, 2025 / Apprentice.io, the creator of the first AI-powered manufacturing platform for life sciences, today announced a strategic partnership with Aprecia, the industry leader in pharmaceutical three-dimensional printing (3DP). This collaboration marks a significant step forward in digitally connected drug manufacturing, combining cutting-edge AI technology with breakthrough 3DP innovation in drug delivery.
Through this partnership, Aprecia will implement Apprentice.io's intelligent manufacturing platform at its Ohio facility to accelerate production workflows designed to ensure consistent, reliable execution at scale. The integration will support Aprecia's mission to revolutionize how medications are produced and delivered using advanced additive manufacturing.
Apprentice's cloud-native platform delivers intuitive digital manufacturing capabilities and no-code integration tools that provide flexibility, scalability, and connectivity appropriate for Aprecia's manufacturing model. As Aprecia continues to grow, this technology foundation will enable rapid deployment and seamless scaling across multiple production sites.
"I believe that Aprecia is the next generation of additive manufacturing," said Angelo Stracquatanio, CEO & Co-founder of Apprentice.io. "They are at the absolute forefront of innovation in life sciences. Combined with our AI native approach to manufacturing, I am looking forward to seeing what we can accomplish in the future."
Aprecia's deployment of Apprentice's technology reflects a shared commitment for next level pharmaceutical manufacturing. The collaboration underscores the industry's rapid evolution toward more sophisticated, data-driven manufacturing approaches that can adapt to and scale complex formulation requirements while maintaining the highest quality standards.
"Aprecia is leading the way in pharmaceutical 3D printing, driven by a commitment to transform patient care through innovation, said Kyle Smith, president and chief operating officer at Aprecia. Our partnership with Apprentice.io strengthens that mission, leveraging AI-powered solutions to scale precision drug delivery and redefine what's possible in oral medication. We will continue to integrate cutting-edge technologies that keep us at the forefront and address the evolving needs of patients and caregivers."
About Aprecia
Aprecia has brought significant change to pharmaceutical manufacturing with advanced 3D printing technology, enhancing the speed, flexibility, and precision of oral medication production. Through strategic partnerships, Aprecia can create personalized medicine and accelerate market entry, setting new standards in the industry.
Located in Mason, Ohio, Aprecia's capabilities include pharmaceutical manufacturing, drug product development, engineering innovation, and analytical methods. For over 20 years, Aprecia has led in pharmaceutical additive manufacturing technologies, establishing 3D printing as a viable pharmaceutical manufacturing option and is continuously exploring ways to improve medicine and patient health outcomes. For more information, visit www.aprecia.com.
About Apprentice
Apprentice is the industry's first agentic manufacturing platform built for a world beyond paper and legacy MES. Apprentice unifies MES, LES, automation, and remote collaboration capabilities together in a modern, no-code platform while simultaneously deploying AI Agents to support every step of manufacturing. The AI Agents operate autonomously to amplify human efforts, optimize processes, and scale throughput while reducing costs. The company's technology drives innovation at every stage-from design and creation to simulation, execution, and optimization. For over a decade, we've helped life sciences companies integrate their people, processes, and systems into a single next-gen platform. Today, Apprentice serves all manufacturing sectors fulfilling the vision of what a digital "Apprentice" can be. For more information, visit www.apprentice.io.
Contact Information:
Kristen Kucks
Director of Communications, Marketing
[email protected]
Justin Foreman
[email protected]
SOURCE: Apprentice.io
View the original press release on ACCESS Newswire
T.Ward--AMWN